MediPoint: Peripheral Vascular Interventions – Global Analysis and Market Forecasts

MediPoint: Peripheral Vascular Interventions – Global Analysis and Market Forecasts Cover

Single Licence: $5995

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
157
Medical Devices
Global

 MediPoint: Peripheral Vascular Interventions – Global Analysis and Market Forecasts

Summary

The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. The rising prevalence of peripheral artery disease (PAD) combined with the increasing endovascular procedure rate will ensure that the market will continue to expand in the coming years. Recent technological advancements within this space, including drug-eluting stents and balloons, bioabsorbable stents (BAS), and polytetrafluoroethylene (PTFE)-covered stents have the potential to revolutionize the future of PAD treatment, as these devices provide improved solutions for complex pathologies. The technologies covered in this report include lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents. This report focuses on the global peripheral vascular interventions market in North America (Canada, Mexico, US), Europe (France, Germany, Italy, Spain, Russia, UK), Asia-Pacific (APAC) (Australia, China, India, Japan, South Korea), and South America (Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different technologies.

Highlights

Key Questions Answered – What is the current and future peripheral vascular interventions market outlook in the developed and emerging markets? What trends are affecting the global market? – Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment? – What are the unmet needs with the current generation of devices? How will emerging technologies fulfill these unmet needs? – What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for peripheral vascular interventions? – What are the challenges that have hindered widespread adoption of newer technologies? – With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global peripheral vascular interventions market?

Scope

– Overview of recent key industry events and analysis of their market impact. – Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2022. – Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market. – Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development. – Analysis of the current and future market competition in the global peripheral vascular interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

– “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons, interventional cardiologists, and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information. Peripheral Vascular Interventions Market Will Climb to $3.4 Billion by 2022, says GlobalData The global market for peripheral vascular interventions, including lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents, will rise from $2.1 billion in 2015 to $3.4 billion by 2022, says research and consulting firm GlobalData. According to the company’s latest report*, this expansion, which will occur at a compound annual growth rate of 6.8%, will be driven by an increased demand for minimally invasive endovascular procedures, greater availability of improved solutions for femoropopliteal artery revascularization, and the rising prevalence of peripheral artery disease (PAD). Premdharan Meyyan, GlobalData’s Analyst covering Medical Devices, explains that the prevalence of PAD is rising worldwide due to an increase in risk factors such as diabetes, hypertension, obesity, and tobacco use, resulting in a greater demand for minimally invasive treatments. An increasing number of physicians trained in endovascular techniques will help to address this. Meyyan comments: “Drug-eluting devices, including DEB and drug-eluting stents, are expected to significantly impact the treatment paradigm of PAD during the forecast period, particularly for complex femoropopliteal and infrapopliteal artery lesions where bare-metal stents and standard balloon angioplasty have not been as effective as long-term treatments. “The development of more efficient drug delivery systems that maintain drug concentration in the vessel wall for longer periods of time will be a significant market opportunity moving forward, as this will improve long-term efficacy.” The current key players within the large and dynamic peripheral interventions market are Abbott Vascular, Boston Scientific, C.R. Bard, Cook Medical, Cordis, Medtronic, and W.L. Gore. Meyyan continues: “Recent high-profile acquisitions, such as Medtronic’s acquisition of Covidien and Cardinal Health’s acquisition of Cordis, will significantly impact the competitive landscape moving forward. “Companies such as Biotronik, B. Braun, Maquet, and Eurocor are also strong potential competitors which are poised for growth due to investment in innovative technologies within this space, including DEB and polytetrafluoroethylene (PTFE)-covered stents.” *MediPoint: Peripheral Vascular Interventions – Global Analysis and Market Forecasts This report provides analysis of the global peripheral vascular interventions arena, including annualized market data from 2015 and forecast to 2022. It discusses the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment within the treatment space. This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

Request more information (Table of Contents, List of table, List of Figures) by using the form below:

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $5995

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.